Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
11.5M
-
Shares change
-
-2.54M
-
Total reported value, excl. options
-
$18.1M
-
Value change
-
-$4.87M
-
Put/Call ratio
-
0.27
-
Number of buys
-
9
-
Number of sells
-
-12
-
Price
-
$1.58
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q3 2023
36 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q3 2023.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.5M shares
of 100M outstanding shares and own 11.44% of the company stock.
Largest 10 shareholders include Long Focus Capital Management, LLC (4.49M shares), Capital International Investors (1.85M shares), CREDIT SUISSE AG/ (1.44M shares), BAILLIE GIFFORD & CO (1.16M shares), MILLENNIUM MANAGEMENT LLC (1.1M shares), PRINCIPAL FINANCIAL GROUP INC (657K shares), MACQUARIE GROUP LTD (227K shares), KBC Group NV (163K shares), OPPENHEIMER & CO INC (121K shares), and MORGAN STANLEY (67.6K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.